Trade Summary

3 days ago, TANG KEVIN, serving as 10% owner Owner at Fulcrum Therapeutics, Inc. (FULC), purchased 249,946 shares at $3.57 per share, for a total transaction value of $891,067.48. Following this transaction, TANG KEVIN now holds 6,913,329 shares of FULC.

This purchase represents a 3.75% increase in TANG KEVIN's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Monday, July 13, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, July 15, 2026 at 7:50 PM ET, 2 days after the trade was made.

Fulcrum Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.